mobile.zenopa.com Homepage Homepage
Employment Role Location
Business Sector Advanced
Phone 01494 818 000
Home > Employer Services > Client List > Grunenthal Ltd

Current Jobs

Current Jobs

Marketing Administrator
Location: Buckinghamshire

Business Account Manager
Location: North West

Grunenthal Ltd Jobs Profile

 

WELCOME TO GRÜNENTHAL UK.

Grünenthal Ltd. is a recently established affiliate of a German family owned Pharmaceutical Company and is situated close to High Wycombe.

Our aim is to create a highly respected Pharmaceutical Company locally through introductions of our own research and development products and acquired brands.

Grünenthal is an independent, research-based, pharmaceutical company with international operations. It has been under family-ownership since its foundation in 1946. Grünenthal's products are marketed in more than 80 countries, and the number of subsidiaries is growing constantly. In the meantime Grünenthal employs round about 4,800 people world-wide, who have made a great contribution to the company's success.

Future consolidation by means of innovative research is an integral part of our company policy. Grünenthal's ambition is to be a leading R&D company in selected indications: pain is our core competence.

Vision

"To become the preferred partners for our customers, providers and employees by delivering all that we promise."

Profile of Grünenthal's key products

Grünenthal GmbH is an independent, research-based and global pharmaceutical company. We specialise in the field of pain therapy, contraception and innovative formulations for established active substances. Grünenthal products are available in more than 100 countries, most of it are prescription medicines.



Jo-Anne
Grunenthal Ltd Account Manager
01494 818 012
(Mon to Fri 0830 to 1800 hours)
jo@zenopa.com

Company Reports

31/12/2007 Accounts



You need to be logged in to view these reports, please login first then return to this page.

Latest News

Grunenthal and partners publish positive data for Nucynta

Grunenthal tablets approved by FDA

Grunenthal announces new phase III tapentadol results

home | our clients | browse news | browse jobs | links | hotel directory | Valid HTML | copyright © 2010 Zenopa Ltd | terms & conditions of use